Skip Navigation
American College of Physicians Logo
  • Subscribe
  • Submit a Manuscript
  • Sign In
    Sign in below to access your subscription for full content
    INDIVIDUAL SIGN IN
    Sign In|Set Up Account
    You will be directed to acponline.org to register and create your Annals account
    INSTITUTIONAL SIGN IN
    Open Athens|Shibboleth|Log In
    Annals of Internal Medicine
    SUBSCRIBE
    Subscribe to Annals of Internal Medicine.
    You will be directed to acponline.org to complete your purchase.
Annals of Internal Medicine Logo Menu
  • Latest
  • Issues
  • Channels
  • CME/MOC
  • In the Clinic
  • Journal Club
  • Web Exclusives
  • Author Info
Advanced Search
  • ‹ PREV ARTICLE
  • This Issue
  • NEXT ARTICLE ›
Summaries for Patients |17 July 2012

Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement


Article, Author, and Disclosure Information
Author, Article, and Disclosure Information
Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.
Summaries for Patients are presented for informational purposes only. These summaries are not a substitute for advice from your own medical provider. If you have questions about this material, or need medical advice about your own health or situation, please contact your physician. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the American College of Physicians.

  • The full report is titled “Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement.” It is in the 17 July 2012 issue of Annals of Internal Medicine (volume 157, pages 120-134). The author is V.A. Moyer, on behalf of the U.S. Preventive Services Task Force.

×
  • ‹ PREV ARTICLE
  • This Issue
  • NEXT ARTICLE ›
Jump To
  • Full Article
  • FULL ARTICLE
  • FULL ARTICLE
    • Who developed these recommendations?
    • What is the problem and what is known about it so far?
    • How did the USPSTF develop these recommendations?
    • What did the authors find?
    • What does the USPSTF recommend that patients and doctors do?
    • What are the cautions related to these recommendations?
  • Figures
  • Tables
  • Supplements
  • Audio/Video
  • Summary for Patients
  • Clinical Slide Sets
  • CME / MOC
  • Comments
  • Twitter Link
  • Facebook Link
  • Email Link
More
  • LinkedIn Link

Who developed these recommendations?

The U.S. Preventive Services Task Force (USPSTF), which is a group of health experts that makes recommendations about preventive health care.

What is the problem and what is known about it so far?

The prostate is an organ in men that surrounds the tube that empties urine from the bladder. Prostate cancer is the most commonly diagnosed non–skin cancer among men in the United States. The most common prostate cancer symptoms are difficult or frequent urination, but many men have no symptoms.
A blood test that measures prostate-specific antigen (PSA) levels can find prostate cancer before symptoms develop. If the PSA level is high, a prostate biopsy may be needed to see whether cancer is actually present. During biopsy, doctors insert a hollow needle into the prostate to obtain a piece of the prostate to examine under a microscope.
At present, there is no way to tell with certainty which cases of prostate cancer are life-threatening and require treatment, and which cases are not. Most prostate cancer grows very slowly, and many men with prostate cancer die of something other than prostate cancer. However, screening puts men at risk for unnecessary worry and adverse effects of treatment with surgery, hormones, or radiation therapy.
In 2008, the USPSTF recommended that men older than 75 years of age not get PSA-based screening and concluded that there was not enough information to make a recommendation for younger men. It wanted to update that recommendation by reviewing studies that have become available since 2008.

How did the USPSTF develop these recommendations?

The USPSTF reviewed published research to measure the benefits and harms of screening for prostate cancer with PSA testing.

What did the authors find?

Good evidence shows that PSA-based screening prevents only 0 to 1 prostate cancer death for every 1000 men screened. No studies show any benefit in overall death rates.
Good evidence shows that PSA-based screening can cause harms, including pain and complications from prostate biopsy and worry about test results. However, the more worrisome harms are related to treatment of prostate cancer found by screening when most of these cases, if not detected by screening, would never have caused problems for the patient. The side effects of prostate cancer treatments include sexual dysfunction, bowel and bladder incontinence, and even death.

What does the USPSTF recommend that patients and doctors do?

For men of any age, the USPSTF recommends that doctors and patients do not screen for prostate cancer because the potential benefits do not outweigh the harms. However, the USPSTF realizes that some men may continue requesting the PSA test and some physicians may continue offering it. The decision to start or continue screening should be an informed one that reflects an understanding of the possible benefits and harms and should respect an individual man's preferences.

What are the cautions related to these recommendations?

These recommendations apply to men of all ages. They do not include the use of the PSA test for monitoring after a diagnosis of prostate cancer or after treatment of prostate cancer. The recommendations may change as new studies become available.
This article was published at www.annals.org on 22 May 2012.

This feature is available only to Registered Users

Subscribe/Learn More
Submit a Comment

0 Comments

PDF
Not Available
Citations
Citation

. Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2012;157:I–44. doi: https://doi.org/10.7326/0003-4819-157-2-201207170-00464

Download citation file:

  • Ris (Zotero)
  • EndNote
  • BibTex
  • Medlars
  • ProCite
  • RefWorks
  • Reference Manager

© 2020

×
Permissions

Published: Ann Intern Med. 2012;157(2):I-44.

DOI: 10.7326/0003-4819-157-2-201207170-00464

0 Citations
Advertisement

See Also
Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement
View MoreView Less

Related Articles
What the U.S. Preventive Services Task Force Missed in Its Prostate Cancer Screening Recommendation
Annals of Internal Medicine; 157 (2): 137-138
Screening for Prostate Cancer: A Review of the Evidence for the U.S. Preventive Services Task Force
Annals of Internal Medicine; 155 (11): 762-771
Screening for Prostate Cancer with Prostate-Specific Antigen Testing: U.S. Preventive Services Task Force Recommendations
Annals of Internal Medicine; 149 (3): I-37
Screening for Prostate Cancer: An Update of the Evidence for the U.S. Preventive Services Task Force
Annals of Internal Medicine; 137 (11): 917-929
View MoreView Less

Journal Club
Review: Prostate cancer screening using PSA does not decrease mortality
Annals of Internal Medicine; 154 (2): JC1-2
Annual screening for prostate cancer did not reduce mortality from prostate cancer
Annals of Internal Medicine; 150 (12): JC6-4
View MoreView Less

Related Topics
Cancer Screening/Prevention
Hematology/Oncology
Prevention/Screening
Prostate Cancer

Cancer Screening/Prevention, Hematology/Oncology, Prevention/Screening, Prostate Cancer.

PubMed Articles
Prevalence, Mortality, and Cause of Death in Charcot-Marie-Tooth Disease in Korea: A Nationwide, Population-Based Study.
Neuroepidemiology 2020.
Gender Differences in Inflammatory Bowel Disease.
Digestion 2020.
View More

Results provided by: PubMed

Advertisement
CME/MOC Activity Requires Users to be Registered and Logged In.
Sign in below to access your subscription for full content
INDIVIDUAL SIGN IN
Sign In|Set Up Account
You will be directed to acponline.org to register and create your Annals account
Annals of Internal Medicine
CREATE YOUR FREE ACCOUNT
Create Your Free Account|Why?
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
The Comments Feature Requires Users to be Registered and Logged In.
Sign in below to access your subscription for full content
INDIVIDUAL SIGN IN
Sign In|Set Up Account
You will be directed to acponline.org to register and create your Annals account
Annals of Internal Medicine
CREATE YOUR FREE ACCOUNT
Create Your Free Account|Why?
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
link to top

Content

  • Home
  • Latest
  • Issues
  • Channels
  • CME/MOC
  • In the Clinic
  • Journal Club
  • Web Exclusives

Information For

  • Author Info
  • Reviewers
  • Press
  • Readers
  • Institutions / Libraries / Agencies
  • Advertisers

Services

  • Subscribe
  • Renew
  • Alerts
  • Current Issue RSS
  • Latest RSS
  • In the Clinic RSS
  • Reprints & Permissions
  • Contact Us
  • Help
  • About Annals
  • About Mobile
  • Patient Information
  • Teaching Tools
  • Annals in the News
  • Share Your Feedback

Awards and Cover

  • Personae (Cover Photo)
  • Junior Investigator Awards
  • Poetry Prize

Other Resources

  • ACP Online
  • Career Connection
  • ACP Advocate Blog
  • ACP Journal Wise

Follow Annals On

  • Twitter Link
  • Facebook Link
acp link acp
silverchair link silverchair

Copyright © 2020 American College of Physicians. All Rights Reserved.

Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Privacy Policy

|

Conditions of Use

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy. | Accept
×

You need a subscription to this content to use this feature.

×
PDF Downloads Require Access to the Full Article.
Sign in below to access your subscription for full content
INDIVIDUAL SIGN IN
Sign In|Set Up Account
You will be directed to acponline.org to register and create your Annals account
INSTITUTIONAL SIGN IN
Open Athens|Shibboleth|Log In
Annals of Internal Medicine
PURCHASE OPTIONS
Buy This Article|Subscribe
You will be redirected to acponline.org to sign-in to Annals to complete your purchase.
CREATE YOUR FREE ACCOUNT
Create Your Free Account|Why?
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
Access to this Free Content Requires Users to be Registered and Logged In. Please Choose One of the Following Options
Sign in below to access your subscription for full content
INDIVIDUAL SIGN IN
Sign In|Set Up Account
You will be directed to acponline.org to register and create your Annals account
Annals of Internal Medicine
CREATE YOUR FREE ACCOUNT
Create Your Free Account|Why?
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×